Clincosm LogoSign in Get a demo

Adenocarcinoma of the Gastroesophageal Junction

Showing 26 - 49 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Gastroesophageal Junction, Esophageal Undifferentiated Carcinoma, Gastric Adenocarcinoma Trial in Buffalo,

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Buffalo, New York
  • +1 more
Nov 14, 2017

A Survivorship Care Plan for Gynaecological Cancer Patients

Completed
  • Adenocarcinoma of the Gastroesophageal Junction
  • +9 more
    • London, United Kingdom
      Royal Marsden Hospital NHS Foundation Trust
    Nov 21, 2017

    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

    Withdrawn
    • Adenocarcinoma of the Esophagus
    • +13 more
    • c-Met inhibitor AMG 337
    • +6 more
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Oct 17, 2017

    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach Trial in Mannheim (5-FU, leucovorin, docetaxel,

    Completed
    • Adenocarcinoma of the Gastroesophageal Junction
    • Adenocarcinoma of the Stomach
    • 5-FU, leucovorin, docetaxel, oxaliplatin (FLOT), trastuzumab
    • Post-operative treatment trastuzumab mono therapy
    • Mannheim, Germany
      Tagestherapiezentrum am ITM & III. Medizinische Klinik Universit
    Jun 16, 2017

    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

    Completed
    Has Results
    • Adenocarcinoma of the Esophagus
    • +8 more
    • Duarte, California
    • +2 more
    Apr 26, 2017

    Physical and Psychosocial Rehabilitation Needs of Patients After

    Completed
    • Adenocarcinoma of the Gastroesophageal Junction
    • +9 more
    • informational intervention
    • +2 more
    • London, England, United Kingdom
      Royal Marsden - London
    Oct 31, 2016

    Adenocarcinoma of the Gastroesophageal Junction, Gastric Cancer Trial in Belgium, Germany, Portugal (capecitabine, cisplatin,

    Terminated
    • Adenocarcinoma of the Gastroesophageal Junction
    • Gastric Cancer
    • Brussels, Belgium
    • +3 more
    Oct 11, 2016

    Adenocarcinoma of the Gastroesophageal Junction, Gastric Cancer Trial in Lille, Reims (biological, drug, procedure)

    Completed
    • Adenocarcinoma of the Gastroesophageal Junction
    • Gastric Cancer
    • cetuximab
    • +7 more
    • Lille, France
    • +1 more
    May 27, 2016

    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer Trial in United States (biological, drug, procedure,

    Completed
    Has Results
    • Adenocarcinoma of the Gastroesophageal Junction
    • Esophageal Cancer
    • panitumumab
    • +5 more
    • Savannah, Georgia
    • +20 more
    Feb 10, 2016

    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer Trial in United States

    Completed
    Has Results
    • Adenocarcinoma of the Gastroesophageal Junction
    • +6 more
    • Sacramento, California
    • +29 more
    Dec 16, 2015

    Adenocarcinoma of the Gastroesophageal Junction, Diffuse Gastric Adenocarcinoma, Gastric Intestinal Type Adenocarcinoma Trial in

    Completed
    Has Results
    • Adenocarcinoma of the Gastroesophageal Junction
    • +4 more
    • Akt Inhibitor MK2206
    • Mobile, Alabama
    • +186 more
    Dec 14, 2015

    Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

    Completed
    Has Results
    • Adenocarcinoma of the Gastroesophageal Junction
    • +8 more
    • Cleveland, Ohio
      Case Western Reserve University
    Apr 15, 2015

    Adenocarcinoma of the Gastroesophageal Junction, Metastatic Gastric Cancer, Advanced Unresectable Gastric Cancer Trial in Boston

    Completed
    Has Results
    • Adenocarcinoma of the Gastroesophageal Junction
    • +2 more
    • BAY 43-9006
    • +2 more
    • Boston, Massachusetts
      Eastern Cooperative Oncology Group
    Nov 19, 2014

    Adenocarcinoma of the Stomach, Adenocarcinoma of the Gastroesophageal Junction Trial in Italy (Irinotecan, Leucovorin,

    Completed
    • Adenocarcinoma of the Stomach
    • Adenocarcinoma of the Gastroesophageal Junction
    • Irinotecan, Leucovorin, 5-Fluorouracil, Docetaxel, Cisplatin
    • Leucovorin, 5-Fluorouracil
    • Fabriano, Ancona, Italy
    • +100 more
    Jul 17, 2014

    Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

    Completed
    Has Results
    • Adenocarcinoma of the Gastroesophageal Junction
    • +8 more
    • Duarte, California
    • +4 more
    May 9, 2014

    Adenocarcinoma of the Gastroesophageal Junction, HER2-positive Breast Cancer, Male Breast Cancer Trial in New York (drug,

    Terminated
    • Adenocarcinoma of the Gastroesophageal Junction
    • +11 more
    • Akt inhibitor MK2206
    • +3 more
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Sep 27, 2013

    Blood and Tissue Samples From Stomach Cancer, Esophageal Cancer,

    Unknown status
    • Adenocarcinoma of the Gastroesophageal Junction
    • +2 more
    • DNA analysis
    • +6 more
    • Cambridge, England, United Kingdom
      Cancer Research UK at Cambridge Research Institute
    Aug 9, 2013

    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer Trial in United Kingdom (drug, other,

    Completed
    • Adenocarcinoma of the Gastroesophageal Junction
    • +4 more
    • Bristol, England, United Kingdom
    • +7 more
    Aug 6, 2013

    Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

    Completed
    • Adenocarcinoma of the Gastroesophageal Junction
    • +8 more
    • irinotecan hydrochloride
    • +4 more
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jun 3, 2013

    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer Trial in New York

    Completed
    • Adenocarcinoma of the Esophagus
    • +5 more
    • erlotinib hydrochloride
    • laboratory biomarker analysis
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jun 3, 2013

    Validation of a Nutrition Screening Tool

    Completed
    • Adenocarcinoma of the Gastroesophageal Junction
    • +9 more
      • London, London .., United Kingdom
        Royal Marsden Hospital NHS Foundation Trust
      May 8, 2013

      Adenocarcinoma of the Gastroesophageal Junction Trial in Lublin (preoperative chemo- and chemoradiotherapy, Surgical resection)

      Unknown status
      • Adenocarcinoma of the Gastroesophageal Junction
      • preoperative chemo- and chemoradiotherapy
      • Surgical resection
      • Lublin, Lubelskie, Poland
        Second Department of General & Gastrointestinal Surgery & Oncolo
      Feb 2, 2013

      Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer Trial in Wolverhampton (quality-of-life assessment)

      Completed
      • Adenocarcinoma of the Gastroesophageal Junction
      • Esophageal Cancer
      • quality-of-life assessment
      • Wolverhampton, England, United Kingdom
        New Cross Hospital
      Nov 28, 2012

      Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer Trial in Cleveland (docetaxel, oxaliplatin, vandetanib)

      Terminated
      • Adenocarcinoma of the Gastroesophageal Junction
      • Esophageal Cancer
      • Cleveland, Ohio
        Case Medical Center, University Hospitals Seidman Cancer Center,
      Aug 19, 2011